Autopsy report · NCT07178665

Pilot Trial of Preop Partial Radiation in Breast Cancer Patients

“10th patient enrolled; interim analysis to be completed by HROC after 3-month follow-up completed for the 10th patient enrolled.”

The sponsor’s own words in the registry.

Life of this trial

• Suspended: paused, and may or may not restart.
• 98 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Phase 1

Sponsor

Rutgers, The State University of New Jersey

Sponsor type

University, hospital or other

Conditions

Early-stage Breast Cancer; Breast Carcinoma; DCIS

Interventions

Radiation: Accelerated Partial Breast Irradiation (APBI)

Participants

98 (planned, not actual)

Sites

10

Countries

United States

Trials that died the same way

• Verapamil vs Steroid to Prevent Keloid Recurrence
  “Objective of study achieved after interim analysis.” (67% match in meaning)
• Vorinostat Plus FND in Relapsed or Refractory Mantle Cell Lymphoma
  “we collected data of a total of 19 patients for an interim analysis. but there are less than 7 responses out of the initial 19 patients.” (63% match in meaning)
• Somatostatin Analogues With Perioperative Antibiotics Versus Prolonged Antibiotics
  “study paused for interim analysis” (62% match in meaning)
• RCT of Mobile Apps & FitBit v. Usual Care
  “Study is paused for interim analysis.” (62% match in meaning)
• Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
  “Pending Interim Analysis” (62% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.